Isotechnika selected for oral presentation at the American Transplant Congress
Wednesday May 28, 9:00 am ET
EDMONTON, May 28 /CNW/ - Isotechnika today announced that the Company has been selected to give an oral presentation as part of the Late Breaking Abstract Session at the 2008 American Transplant Congress in Toronto, Canada.
The final Phase 2b kidney transplant trial (PROMISE) results will be presented during an oral presentation by Dr. Osama Gaber, Director of Transplantation, Vice-Chair for Administration and Faculty Affairs, Department of Surgery, The Methodist Hospital, Cornell University in New York. Dr. Gaber, as one of the principal investigators in the PROMISE trial, will present detailed data including the primary endpoint as determined by biopsy proven acute rejection and relevant safety data. Dr. Gaber's presentation is scheduled to take place on Tuesday, June 3 at 4:50 p.m. ET. |
